Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 80: 574-582, 1996;
8750-7587/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du, H. K.
Right arrow Articles by Ou, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du, H. K.
Right arrow Articles by Ou, L. C.

Journal of Applied Physiology, Vol 80, Issue 2 574-582, Copyright © 1996 by American Physiological Society

ARTICLES

Pathophysiological effects of hemodilution in chronic mountain sickness in rats

H. K. Du, Y. J. Lee, G. L. Colice, J. C. Leiter and L. C. Ou
Department of Physiology and Medicine, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA.

We examined the effect of isovolemic hemodilution in a rat model of chronic mountain sickness (CMS). After 30 days at simulated high altitude (5,500 m), Hilltop rats had developed evidence of CMS: severe hypoxemia, polycythemia, and pulmonary arterial hypertension. Isovolemic hemodilution to a mean hematocrit of 46 +/- 5% was well tolerated by both the hypoxia-sensitive Hilltop rats and the companion Madison rat strain that does not develop CMS. After hemodilution, we found no evidence of sustained improvements in ventilation or gas exchange in either strain. Despite the fall in blood viscosity, cardiac output increased only marginally, and pulmonary arterial hypertension persisted in the Hilltop rats. Vascular hindrance increased after hemodilution, preventing a significant decline in pulmonary and systemic vascular resistances in the Hilltop rats. Blood O2 content and the coefficient of O2 delivery fell after hemodilution, but O2 consumption was sustained at a normal level after hemodilution by increasing the extraction fraction in the Hilltop strain. There was systemic hypotension through the first day of hemodilution, but this was the only apparent adverse effect of hemodilution. We conclude that isovolemic hemodilution was well tolerated despite the reduction in tissue O2 delivery. However, hemodilution failed to improve any of the respiratory and cardiovascular manifestations of CMS in Hilltop rats.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
L. C. Ou, S. Salceda, S. J. Schuster, L. M. Dunnack, T. Brink-Johnsen, J. Chen, and J. C. Leiter
Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness
J Appl Physiol, April 1, 1998; 84(4): 1242 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. A. QUINN, H.-K. DU, B. TAYLOR THOMPSON, and C. A. HALES
Amiloride Analogs Inhibit Chronic Hypoxic Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1263 - 1268.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online